<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04598724</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-20809</org_study_id>
    <nct_id>NCT04598724</nct_id>
  </id_info>
  <brief_title>Addressing Barriers to Palliative Care Use in Bladder Cancer</brief_title>
  <official_title>Addressing Barriers to Palliative Care Use in Bladder Cancer Through Better Understanding of Knowledge and Belief Development</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>H. Lee Moffitt Cancer Center and Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>H. Lee Moffitt Cancer Center and Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators plan to establish an in-depth understanding of knowledge and beliefs about&#xD;
      palliative care in advanced Bladder Cancer patients and their caregivers, and to identify&#xD;
      factors associated with positive and negative experiences with palliative care services among&#xD;
      those who have received them.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 22, 2020</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Actual">May 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development of palliative care knowledge and beliefs</measure>
    <time_frame>12 Months</time_frame>
    <description>Thematic analysis of interviews transcriptions to identify the themes that underpin the development of palliative care beliefs among patients with muscle invasive bladder cancer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion with accurate palliative care knowledge and beliefs</measure>
    <time_frame>12 Months</time_frame>
    <description>Proportion of patients correctly answering each palliative care knowledge question.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Association between Bladder Cancer stage and palliative care knowledge</measure>
    <time_frame>12 Months</time_frame>
    <description>Analysis of variance calculated for the mean number of subjects with each cancer stage correctly answering each palliative care knowledge question</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">54</enrollment>
  <condition>Muscle-Invasive Bladder Carcinoma</condition>
  <condition>Bladder Cancer Stage II</condition>
  <condition>Bladder Cancer Stage III</condition>
  <condition>Bladder Cancer Stage IV</condition>
  <arm_group>
    <arm_group_label>Bladder Cancer Patient Participants</arm_group_label>
    <description>Participants will be scheduled for one-on-one interviews that will occur over Zoom or telephone.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Care Givers for Bladder Cancer Patient Participants</arm_group_label>
    <description>Participants will be scheduled for one-on-one interviews that will occur over Zoom or telephone.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Surveys</intervention_name>
    <description>Survey will be administered involving questions regarding knowledge and perception of palliative care.</description>
    <arm_group_label>Bladder Cancer Patient Participants</arm_group_label>
    <arm_group_label>Care Givers for Bladder Cancer Patient Participants</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Bladder Cancer patient participants and care givers will be recruited from the Moffitt&#xD;
        Cancer Genitourinary Oncology clinic and the Supportive Care clinic.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligibility for both patient and caregiver participants will include:&#xD;
&#xD;
          -  age â‰¥18 years&#xD;
&#xD;
          -  able to speak and read English&#xD;
&#xD;
          -  cognitively able to participate in study tasks&#xD;
&#xD;
          -  willing to participate in surveys, semi-structured interviews, and/or focus groups&#xD;
&#xD;
          -  able to participate in either a Zoom meeting or phone interview&#xD;
&#xD;
          -  able to complete an emailed or paper survey&#xD;
&#xD;
          -  Patient Participants: a diagnosis of muscle-invasive or locally advanced bladder&#xD;
             cancer (stages II-IV).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients and caregivers will be excluded if unable to provide verbal or written&#xD;
             consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Gilbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Moffitt Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Moffitt Cancer Center</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://moffitt.org/clinical-trials-research/clinical-trials/</url>
    <description>Moffitt Cancer Center Clinical Trial Search</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 16, 2020</study_first_submitted>
  <study_first_submitted_qc>October 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bladder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

